Rochelle Mills

Rochelle Mills

Managing Partner & Senior Medical Writer at SRM Management Science Company

Richmond, Virginia, United States
731 followers 500+ connections

About

PhD scientist with expertise in the fields of medical writing, regulatory submissions, clinical and nonclinical summaries, oncology, immunotherapy, infectious disease (antibacterial, antifungal, and antiviral), vaccines and adjuvants, pain management, cardiology, and toxicology. Excited to contribute to well-designed studies and communicate critical data and results in written or oral form. Invigorated by team work and collaboration.

Interested in networking and collaboration to advance research and progress personally as a scientific/regulatory writer. Also interested in advancing the careers of women in science through mentoring and education.

Specialties: Regulatory & Scientific Writing, Project Management, GCP, GLP & Nonclinical, Oncology, Immunology/Immunotherapy, Toxicology, Vaccines, Infectious Disease.

Activity

Join now to see all activity

Experience

  • Managing Partner & Senior Medical Writer

    SRM Management Science Company

    - Present 4 years 11 months

    Richmond, Virginia Area

    SRM Management Science Company is a medical and science writing company with experience in International Council for Harmonisation (ICH) Common Technical Document (CTD) and Good Laboratory Practice (GLP) documents.

    Submission and document preparation experience includes Phase 1 through 4 clinical study reports (CSRs); safety narratives; study protocols and amendments; integrated summaries of efficacy and safety; clinical summaries and overviews; Investigator’s Brochures (IBs); briefing…

    SRM Management Science Company is a medical and science writing company with experience in International Council for Harmonisation (ICH) Common Technical Document (CTD) and Good Laboratory Practice (GLP) documents.

    Submission and document preparation experience includes Phase 1 through 4 clinical study reports (CSRs); safety narratives; study protocols and amendments; integrated summaries of efficacy and safety; clinical summaries and overviews; Investigator’s Brochures (IBs); briefing documents; and nonclinical summaries of pharmacology, pharmacokinetics, and toxicology.

    Advanced proficiency in Microsoft Office Suite, Accenture (StartingPoint) templates, Adobe Acrobat, American Medical Association (AMA) Style, PleaseReview, SharePoint, Endnote, and GraphPad Prism.

  • Whitsell Innovations, Inc. Graphic

    Medical Writer & Consultant

    Whitsell Innovations, Inc.

    - 4 years 10 months

    Chapel Hill, North Carolina

    WI is a is a full-service medical and scientific writing company with experience in Good Clinical Practice (GCP), Good Manufacturing Practice (GMP), and Good Laboratory Practice (GLP) writing.

    Medical Writing: Responsible for authoring, editing, and quality control of clinical and nonclinical documents to support global regulatory submissions, including study protocols, Phase 1 through 4 clinical study reports (CSRs), safety narratives, integrated efficacy and safety summaries, briefing…

    WI is a is a full-service medical and scientific writing company with experience in Good Clinical Practice (GCP), Good Manufacturing Practice (GMP), and Good Laboratory Practice (GLP) writing.

    Medical Writing: Responsible for authoring, editing, and quality control of clinical and nonclinical documents to support global regulatory submissions, including study protocols, Phase 1 through 4 clinical study reports (CSRs), safety narratives, integrated efficacy and safety summaries, briefing documents, and Investigator’s Brochures. In-house expert on nonclinical pharmacokinetic, pharmacodynamic, and toxicologic summaries.

    Project Management: Coordinated with clients and publishing contacts to develop efficient plans and timelines for the production, review, quality control, and finalization of content supporting regulatory submissions involving multiple writers, documents, and timelines.

    Internal Expertise: Trained, developed, and mentored other writers and interns. Wrote an internal CSR Authoring Guide based on real-world experience. Presented internal webinars on advanced Microsoft Word functionality, nonclinical drug development and documents, biologics, biosimilars, and infectious disease. Authored meeting abstracts on biologics, biosimilars, and nonclinical summaries.

  • Burleson Research Technologies, Inc. (BRT) Graphic

    GLP Study Director/Principal Investigator

    Burleson Research Technologies, Inc. (BRT)

    - 4 years 5 months

    Raleigh-Durham, North Carolina Area

    BRT is a Contract Research Organization (CRO) that provides clients from the biotechnology, pharmaceutical, chemical manufacturing, and healthcare industries with proof-of-concept, preclinical, and toxicology studies.

    Project Management: Ensured quality of contract and in-house study design, conduct, documentation, and data analysis. Responsible for client satisfaction and meeting firm deadlines. Served as center of communication between clients, BRT leadership, BRT quality assurance…

    BRT is a Contract Research Organization (CRO) that provides clients from the biotechnology, pharmaceutical, chemical manufacturing, and healthcare industries with proof-of-concept, preclinical, and toxicology studies.

    Project Management: Ensured quality of contract and in-house study design, conduct, documentation, and data analysis. Responsible for client satisfaction and meeting firm deadlines. Served as center of communication between clients, BRT leadership, BRT quality assurance staff, and BRT laboratory staff. Managed expenditures for projects. Coordinated collaborations for immunotoxicology model development.

    Good Laboratory Practice (GLP): Responsible for the technical conduct of immunotoxicological studies (bacterial and viral host resistance, cell-based, & bioanalytical), including generation of study protocols, interpretation of results, and generation of study reports. Assured that all applicable GLP regulations were followed.

    Scientific Leadership: Served as a subject matter expert for assay troubleshooting and technical skills. Lead development of novel assays and wrote company SOPs. Directed portions of staff training. Lead assay and equipment validation. Generated scientific meeting abstracts.

  • Graduate Women in Science, Research Triangle Chapter

    Graduate Women in Science, Research Triangle Chapter

    1 year 6 months

    • President

      Graduate Women in Science, Research Triangle Chapter

      - 1 year 1 month

      Raleigh-Durham, North Carolina Area

      Nationally, the mission of GWIS is to advance the participation and recognition of women in science, and to foster research through grants, awards, and fellowships. Locally, the Research Triangle chapter gives its members a route to diversify their scientific connections and become a part of the larger Triangle community. GWIS fosters networking/professional development, provides educational outreach opportunities, and supports those preparing fellowship applications.

      Leadership: Lead…

      Nationally, the mission of GWIS is to advance the participation and recognition of women in science, and to foster research through grants, awards, and fellowships. Locally, the Research Triangle chapter gives its members a route to diversify their scientific connections and become a part of the larger Triangle community. GWIS fosters networking/professional development, provides educational outreach opportunities, and supports those preparing fellowship applications.

      Leadership: Lead officer planning meetings. Generated event topic ideas. Lead event planning. Organized volunteers and delegated duties. Recruited chapter leadership. Updated website content.

      Successful Events:
      Seminar by Dr. Susan Henning (UNC-Chapel Hill)
      Linked In for Scientists Seminar (RTI International)
      Duke Lemur Center Tour
      Silent Auction Fundraiser and Networking Event
      Annual GWIS Career Symposium
      Holiday Networking Event with WIB and AWIS (Nature Research Center)
      Biology Workshop for STEM 1st graders
      Equality for Women in Science Discussion & Dinner (UNC-Chapel Hill)
      GWIS Booth at the NIEHS career fair
      Hosted a meeting with a Women in Science delegation from India
      Recruited volunteers for local museums and the NC Science Festival
      Assertive Communication & Negotiation Panel (Duke University)

    • Secretary

      Graduate Women in Science, Research Triangle Chapter

      - 6 months

      Raleigh-Durham, North Carolina Area

      Team Work & Communication: Lead chapter electronic communications. Organized meeting minutes and officer tasks. Advertised events through email, LinkedIn, and Facebook. Updated website content.

  • Global Vaccines, Inc. Graphic

    Staff Fellow

    Global Vaccines, Inc.

    - 2 years 2 months

    Research Triangle Park, North Carolina

    Global Vaccines, Inc. was a not-for-profit company that developed and acquired new technologies to vaccinate against diseases such as polio, Dengue fever, malaria, and influenza. One adjuvant technology under development involved virus-like replicon particles, which were designed to activate the immune response by appearing to be a virus. Replicon particles can be co-delivered with soluble protein antigens from disease-causing pathogens to boost the protective immune response.

    Project…

    Global Vaccines, Inc. was a not-for-profit company that developed and acquired new technologies to vaccinate against diseases such as polio, Dengue fever, malaria, and influenza. One adjuvant technology under development involved virus-like replicon particles, which were designed to activate the immune response by appearing to be a virus. Replicon particles can be co-delivered with soluble protein antigens from disease-causing pathogens to boost the protective immune response.

    Project Management: Characterized the vaccine adjuvant properties of 4 viral replicon particles in vivo and in vitro. Optimized the production of viral replicon particles by increasing yield per batch. Managed schedules and training of 2 staff members. Successfully collaborated with two academic laboratories.

    Molecular Biology Expertise: Engineered a safer form of viral replication particles through genetic manipulation. Created novel immunoassay reagents. Developed new protocols for measuring adjuvant particle concentration and protein expression.

    Team Work: Coordinated detection of Dengue virus in vaccinated monkeys exposed to the virus. Wrote and edited company SOPs. Authored and edited F32 & R01 grant applications.

    American Society for Virology Postdoctoral Fellow Travel Award, 2011.

  • North Carolina State University Graphic

    Graduate Research Assistant (NIH Ruth L. Kirschstein National Research Service Award Trainee)

    North Carolina State University

    - 4 years 4 months

    Raleigh-Durham, North Carolina Area

    Dr. Gregg Dean's research laboratory focuses on the immunopathology of feline and human immunodeficiency viruses (FIV, HIV), which both cause AIDS in their respective hosts. Rochelle was a participant in the competitive NIH/NCSU Molecular Biotechnology Training Program from 2006-2008.

    Dissertation Title: “The role of regulatory T cells during feline immunodeficiency virus infection in cats.”

    Immunology Expertise: Employed monoclonal antibody therapy to deplete immunosuppressive…

    Dr. Gregg Dean's research laboratory focuses on the immunopathology of feline and human immunodeficiency viruses (FIV, HIV), which both cause AIDS in their respective hosts. Rochelle was a participant in the competitive NIH/NCSU Molecular Biotechnology Training Program from 2006-2008.

    Dissertation Title: “The role of regulatory T cells during feline immunodeficiency virus infection in cats.”

    Immunology Expertise: Employed monoclonal antibody therapy to deplete immunosuppressive Treg cells in acutely and chronically FIV-infected cats. Determined the influence of Treg cell suppression during lentiviral pathogenesis. Developed novel assays to measure adaptive immune responses to FIV and to quantify virus. Authored 3 peer-reviewed publications and several meeting abstracts.

    Project Management: Managed 4 in vivo studies involving 58 research felines. Designed sampling schedule and assays to address specific aims of studies. Coordinated schedules between 5 research staff. Trained other students and scientists.

  • Global Vaccines, Inc. Graphic

    Intern

    Global Vaccines, Inc.

    - 2 months

    Raleigh-Durham, North Carolina Area

    Molecular Experience: Optimized an electroporation protocol for RNA and DNA incorporation into mammalian cell lines in order to develop a system for production of viral adjuvant particles.

  • University of Alabama Graphic

    Undergraduate Research Assistant & Howard Hughes Medical Research Intern

    University of Alabama

    - 2 years 5 months

    Tuscaloosa, Alabama Area

    Dr. Gary Sloan's research laboratory focuses on the study of extracellular enzymes produced by staphylococci and streptococci that kill closely related organisms and the possible evolutionary relationships among some of these enzymes and studies on the cell wall modifications that allow these organisms to be resistant to their own bacteriolytic enzymes.

    Microbiology Experience: Determined the structural changes in gram-positive bacterial cell walls conferred by the endopeptidase…

    Dr. Gary Sloan's research laboratory focuses on the study of extracellular enzymes produced by staphylococci and streptococci that kill closely related organisms and the possible evolutionary relationships among some of these enzymes and studies on the cell wall modifications that allow these organisms to be resistant to their own bacteriolytic enzymes.

    Microbiology Experience: Determined the structural changes in gram-positive bacterial cell walls conferred by the endopeptidase resistance gene. Research resulted in co-authorship of 2 publications.

    Molecular Experience: Determined protein production by gram-positive bacterial strains. Measured the antimicrobial activity of zoocin A.

    Dr. David Oppenheimer's research laboratory focuses on understanding how the assembly and disassembly of the actin and microtubule cytoskeletons are regulated. Cytoskeleton dynamics underlie many fundamental cellular processes such as control of cell shape, cell movement, and membrane trafficking.

    Molecular Experience: Induced mutations in trichome cell shape of Arabidopsis plants. Performed restriction enzyme digests and DNA gels to study genes that control cell shape.

  • Southern Research Institute Graphic

    Research Assistant I

    Southern Research Institute

    - 3 years 1 month

    Birmingham, Alabama Area

    Southern Research immunology services assist clients in the drug development process by analyzing potential immune system involvement for a diverse range of compounds including biologics, vaccines, adjuvants, and anti-cancer/anti-HIV compounds.

    Immunology Experience: Co-developed a flow cytometric assay to assess natural killer cell activity. Developed and optimized an ELISA to measure anti-sheep red blood cell mouse IgM to quantify immunosuppressive effects of pharmaceutical drugs…

    Southern Research immunology services assist clients in the drug development process by analyzing potential immune system involvement for a diverse range of compounds including biologics, vaccines, adjuvants, and anti-cancer/anti-HIV compounds.

    Immunology Experience: Co-developed a flow cytometric assay to assess natural killer cell activity. Developed and optimized an ELISA to measure anti-sheep red blood cell mouse IgM to quantify immunosuppressive effects of pharmaceutical drugs. Performed immunoassays and immunohistochemistry assays.

    Performed work under GLP guidelines. This position was an internship during 2 school years and full-time over 3 summers.

Education

  • North Carolina State University Graphic

    North Carolina State University

    PhD Immunology, minor biotechnology

    -

    Activities and Societies: Lectured on quantitative PCR for graduate students and in an immunology laboratory for DVM students. Manuscript co-reviewer for Blood. Mentored two DVM students in the Merck-Merial Veterinary Scholars Program. Recruited and mentored a high school student during a semester-long research project. NCSU College of Veterinary Medicine Graduate Student Association Secretary. NC DNA Day Mentor. Organized science outreach activities for Dr. Gregg Dean’s laboratory.

    Ruth L. Kirschstein National Research Service Award Trainee in the NCSU Molecular Biotechnology Training Program, 2006-2008.
    Keystone Symposia HIV Pathogenesis Student Travel Scholarship, 2008.

  • The University of Alabama Graphic

    University of Alabama

    BS Microbiology and Immunology

    -

    Activities and Societies: Howard Hughes Medical Research Intern in 2003 and 2004. Tutored for the University of Alabama Rural Science Scholars Program. Managed an undergraduate summer intern.

  • University of Miami Graphic

    University of Miami

    Microbiology and Immunology

    -

Volunteer Experience

  • Secretary

    Graduate Student Association, College of Veterinary Medicine (NCSU)

    - 1 year

  • Chapter Adviser

    Graduate Women in Science, Rho Tau Chapter

    - 2 years 1 month

    Science and Technology

  • Chair, Chapter Establishment Committee

    Graduate Women in Science, National

    - 2 years

    Science and Technology

  • Member, Programs Committee

    Immunotoxicology Specialty Section, Society of Toxicology

    - 1 year 3 months

    Science and Technology

Publications

  • Murine Gammaherpesvirus-68 (MHV-68) is Not Horizontally Transmitted Amongst Laboratory Mice by Cage Contact

    Journal of Immunotoxicology

    Other authors
  • An Alphavirus Vector-Based Tetravalent Dengue Vaccine Induces a Rapid and Protective Immune Response in Macaques That Differs Qualitatively from Immunity Induced by Live Virus Infection

    Journal of Virology

    Other authors
  • Regulatory T cell depletion prior to acute feline immunodeficiency virus infection does not alter disease pathogenesis.

    PLoS ONE

    Feline immunodeficiency virus (FIV) infection in cats follows a disease course similar to HIV-1, including a short acute phase characterized by high viremia, and a prolonged asymptomatic phase characterized by low viremia and generalized immune dysfunction. CD4+CD25hiFoxP3+ immunosuppressive regulatory T (Treg) cells have been implicated as a possible cause of immune dysfunction during FIV and HIV-1 infection, as they are capable of modulating virus-specific and inflammatory immune responses…

    Feline immunodeficiency virus (FIV) infection in cats follows a disease course similar to HIV-1, including a short acute phase characterized by high viremia, and a prolonged asymptomatic phase characterized by low viremia and generalized immune dysfunction. CD4+CD25hiFoxP3+ immunosuppressive regulatory T (Treg) cells have been implicated as a possible cause of immune dysfunction during FIV and HIV-1 infection, as they are capable of modulating virus-specific and inflammatory immune responses. Additionally, the immunosuppressive capacity of feline Treg cells has been shown to be increased during FIV infection. We have previously shown that transient in vivo Treg cell depletion during asymptomatic FIV infection reveals FIV-specific immune responses suppressed by Treg cells. In this study, we sought to determine the immunological influence of Treg cells during acute FIV infection. We asked whether Treg cell depletion prior to infection with the highly pathogenic molecular clone FIV-C36 in cats could alter FIV pathogenesis. We report here that partial Treg cell depletion prior to FIV infection does not significantly change provirus, viremia, or CD4+ T cell levels in blood and lymphoid tissues during the acute phase of disease. The effects of anti-CD25 mAb treatment are truncated in cats acutely infected with FIV-C36 as compared to chronically infected cats or FIV-naïve cats, as Treg cell levels were heightened in all treatment groups included in the study within two weeks post-FIV infection. Our findings suggest that the influence of Treg cell suppression during FIV pathogenesis is most prominent after Treg cells are activated in the environment of established FIV infection.

    Other authors
    See publication
  • In vivo depletion of CD4+CD25hi regulatory T cells is associated with improved antiviral responses in cats chronically infected with feline immunodeficiency virus.

    Virology

    Regulatory T (Treg) cells are activated and suppress immune responses during infection, and are characterized as CD4(+)CD25(hi)FOXP3(+). Ex vivo studies demonstrate that Treg cells potentially suppress anti-HIV-1 T cell responses. Lentivirus-induced CD4(+)CD25(hi) Treg cells were first described in feline immunodeficiency virus (FIV)-infected cats. In the present study we demonstrate that anti-feline CD25 monoclonal antibody (mAb) therapy depletes Treg cells in FIV-infected cats for 4 weeks and…

    Regulatory T (Treg) cells are activated and suppress immune responses during infection, and are characterized as CD4(+)CD25(hi)FOXP3(+). Ex vivo studies demonstrate that Treg cells potentially suppress anti-HIV-1 T cell responses. Lentivirus-induced CD4(+)CD25(hi) Treg cells were first described in feline immunodeficiency virus (FIV)-infected cats. In the present study we demonstrate that anti-feline CD25 monoclonal antibody (mAb) therapy depletes Treg cells in FIV-infected cats for 4 weeks and does not exacerbate viral replication or proinflammatory cytokine production. Significant FIV-specific immune responses are revealed in Treg cell-depleted cats. These anti-FIV effector cells exist prior to Treg cell depletion and are not expanded while Treg cells are depleted. Importantly, cats receiving the Treg cell-depleting mAb are able to produce a robust humoral response to new antigen. We propose that short-term in vivo Treg cell depletion during chronic HIV-1 infection could provide a window of opportunity for therapeutic vaccination in individuals with controlled viral replication.

    Other authors
    See publication
  • In vivo depletion of CD4+CD25+ regulatory T cells in cats.

    Journal of Immunological Methods

    To establish a characterized model of regulatory T cell (Treg) depletion in the cat we assessed the kinetics of depletion and rebound in peripheral and central lymphoid compartments after treatment with anti-CD25 antibody as determined by cell surface markers and FOXP3 mRNA expression. An 82% decrease in circulating CD4+CD25+ Tregs was observed by day 11 after treatment. CD4+CD25+ cells were also reduced in the thymus (69%), secondary lymphoid tissues (66%), and gut (67%). Although CD4+CD25+…

    To establish a characterized model of regulatory T cell (Treg) depletion in the cat we assessed the kinetics of depletion and rebound in peripheral and central lymphoid compartments after treatment with anti-CD25 antibody as determined by cell surface markers and FOXP3 mRNA expression. An 82% decrease in circulating CD4+CD25+ Tregs was observed by day 11 after treatment. CD4+CD25+ cells were also reduced in the thymus (69%), secondary lymphoid tissues (66%), and gut (67%). Although CD4+CD25+ cells rebound by day 35 post-treatment, FOXP3 levels remain depressed suggesting anti-CD25 antibody treatment has a sustainable diminutive effect on the Treg population. To determine whether CD25+ Treg depletion strategies also deplete activated CD25+ effector cells, cats were immunized with feline immunodeficiency virus (FIV) p24-GST recombinant protein, allowing them to develop a measurable memory response, prior to depletion with anti-CD25 antibody. Anti-FIV p24-GST effector cell activity in peripheral blood after depletion was sustained as determined by antigen-specific T cell proliferation and humoral responses against FIV p24-GST with an ELISA for antigen-specific feline IgG. Furthermore, development of an anti-mouse response in Treg-depleted cats was similar to control levels indicating the retained capacity to respond to a novel antigen. We conclude that despite alterations in CD25+ cell levels during depletion, the feline immune system remains functional. We demonstrate here a model for the study of disease pathogenesis in the context of reduced numbers of immunosuppressive CD4+CD25+ Tregs throughout the feline immune system.

    Other authors
    See publication
  • Plasmid-specified FemABX-like immunity factor in Staphylococcus sciuri DD 4747.

    FEMS Microbiology Letters

    A plasmid from Staphylococcus sciuri DD 4747 had three open reading frames: a replication gene, an N-acetylmuramyl-l-alanine amidase-like gene, and a gene similar to the lysostaphin endopeptidase resistance gene (epr/lif). The epr-like gene was introduced into S. aureus RN4220; the recombinant strain was more resistant to lysostaphin endopeptidase and its cell wall peptidoglycan contained more serines and fewer glycines than the parental strain with the shuttle vector alone. Based on both its…

    A plasmid from Staphylococcus sciuri DD 4747 had three open reading frames: a replication gene, an N-acetylmuramyl-l-alanine amidase-like gene, and a gene similar to the lysostaphin endopeptidase resistance gene (epr/lif). The epr-like gene was introduced into S. aureus RN4220; the recombinant strain was more resistant to lysostaphin endopeptidase and its cell wall peptidoglycan contained more serines and fewer glycines than the parental strain with the shuttle vector alone. Based on both its function and its similarity to femAB, this gene is a member of the femABX-like immunity gene family. Furthermore, this is the first example of a femABX-like immunity gene that is not linked to the gene for the bacteriolytic enzyme against which it specifies immunity.

    Other authors
    • Lucie Heath
    • Shaw Gargis
    • Heather Johnson
    • Harry Heath
    • Paul LeBlanc
    • Gary Sloan
    See publication
  • The streptococcolytic enzyme zoocin A is a penicillin-binding protein

    FEMS Microbiology Letters

    Zoocin A is a streptococcolytic enzyme produced by Streptococcus equi subsp. zooepidemicus 4881 that has an unknown site of action on the peptidoglycans of susceptible organisms. Analysis of a mutant strain in which the genes for zoocin A and resistance to zoocin A were inactivated revealed that this strain was more susceptible to β-lactam antibiotics than the parental organism. Purified zoocin A had weak β-lactamase activity, bound radioactive penicillin covalently, and its streptococcolytic…

    Zoocin A is a streptococcolytic enzyme produced by Streptococcus equi subsp. zooepidemicus 4881 that has an unknown site of action on the peptidoglycans of susceptible organisms. Analysis of a mutant strain in which the genes for zoocin A and resistance to zoocin A were inactivated revealed that this strain was more susceptible to β-lactam antibiotics than the parental organism. Purified zoocin A had weak β-lactamase activity, bound radioactive penicillin covalently, and its streptococcolytic activity was inhibited by penicillin. Thus, zoocin A is a penicillin-binding protein and presumably is a d-alanyl endopeptidase.

    Other authors
    • Lucie Heath
    • Harry Heath
    • Paul LeBlanc
    • Muriel DuFour
    • Robin Simmonds
    • Gary Sloan
    See publication

Courses

  • American College of Toxicology: Toxicology for Pharmaceutical and Regulatory Scientists (April 2016)

    -

Projects

  • Presentation: Managing Your Online Professional Network

    -

    Presented hour-long seminars about maximizing the utility of LinkedIn and networking to six groups from 2012-2015.

    • RTI International, RTP, NC, June 2012
    • The Church of Jesus Christ of Latter-day Saints, Durham, NC, September 2012
    • University of Alabama at Birmingham Graduate Career Awareness and Trends (UAB GCAT), Birmingham, AL, September 2012
    • University of North Carolina-Chapel Hill Career Symposium for Graduate Students and Post-doctoral Scholars, February 2013 (with…

    Presented hour-long seminars about maximizing the utility of LinkedIn and networking to six groups from 2012-2015.

    • RTI International, RTP, NC, June 2012
    • The Church of Jesus Christ of Latter-day Saints, Durham, NC, September 2012
    • University of Alabama at Birmingham Graduate Career Awareness and Trends (UAB GCAT), Birmingham, AL, September 2012
    • University of North Carolina-Chapel Hill Career Symposium for Graduate Students and Post-doctoral Scholars, February 2013 (with Katherine Nobles)
    • The Church of Jesus Christ of Latter-day Saints, Raleigh, NC, February 2014
    • Duke University Women in Science & Engineering, Durham, NC, January 2015

    See project

Honors & Awards

  • American Society for Virology Postdoctoral Fellow Travel Award

    -

  • Keystone Symposia HIV Pathogenesis Student Travel Scholarship

    -

  • Ruth L. Kirschstein National Research Service Award Trainee

    NIH/NCSU Molecular Biotechnology Training Program

    Participated 2006-2008.

  • Howard Hughes Medical Research Intern

    -

  • Howard Hughes Medical Research Intern

    -

Organizations

  • American Medical Writers Association

    -

    - Present
  • Society of Toxicology

    -

    - Present
  • Graduate Women in Science

    President, Secretary, Chapter Adviser, Chapter Establishment Committee Chair

    -
  • Women in Bio

    -

    -
  • American Society for Virology

    -

    -
  • American Association of Immunologists

    -

    -
  • American Society for Microbiology

    -

    -

Recommendations received

More activity by Rochelle

View Rochelle’s full profile

  • See who you know in common
  • Get introduced
  • Contact Rochelle directly
Join to view full profile

Other similar profiles

Explore collaborative articles

We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.

Explore More

Others named Rochelle Mills in United States

Add new skills with these courses